Sci-Tech North Carolina: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech North Carolina.

Press releases published on September 24, 2026

Sep. 24, 2026

Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting

Indeterminate GlobeNewswire

Sep. 24, 2026

Trident Regains Compliance with Nasdaq Minimum Market Value of Listed Securities Requirement

Indeterminate GlobeNewswire

Sep. 24, 2026

Sofwave Receives NMPA Approval in Mainland China

Indeterminate GlobeNewswire

Sep. 24, 2026

3 E Network Partners with HashBeaver to Expand Web3 Distribution of Finnish Green AI Compute

Indeterminate GlobeNewswire

Sep. 24, 2026

Immuneering to Present at the ESMO Congress 2026

Indeterminate GlobeNewswire

Sep. 24, 2026

Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products

Indeterminate GlobeNewswire

Sep. 24, 2026

Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October

Indeterminate GlobeNewswire

Sep. 24, 2026

Build Smarter, More Resilient 48V Power Systems with Energy-Aware Digital Power Monitoring from Microchip

Indeterminate GlobeNewswire

Sep. 24, 2026

Kraig Biocraft Laboratories Reaches Major Scientific Milestone with Completion of Functional and Living Atlas Gene Library

Indeterminate GlobeNewswire

Sep. 24, 2026

Coave Therapeutics to Present New Data on Wet AMD Gene Therapy Program at 26th Euretina Congress as it Advances towards the Clinic

Indeterminate GlobeNewswire

Sep. 24, 2026

Pasqal Reports First Half 2026 Financial Results

Indeterminate GlobeNewswire

Sep. 24, 2026

Atavistik Bio Announces Strategic Research Collaboration with Roche to Discover and Develop Novel Allosteric Therapeutics

Indeterminate GlobeNewswire

Sep. 24, 2026

Private LLM for a Law Firm: The Questions Firms Ask Before They Build One

Indeterminate GlobeNewswire

Sep. 24, 2026

Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting

Indeterminate GlobeNewswire

Sep. 24, 2026

Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development

Indeterminate GlobeNewswire

Sep. 24, 2026

Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder

Indeterminate GlobeNewswire

Sep. 24, 2026

Cullinan Therapeutics Highlights Fourth Quarter 2026 Milestones Across Immunology and Oncology T Cell Engager Portfolio

Indeterminate GlobeNewswire

Sep. 24, 2026

Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million

Indeterminate GlobeNewswire

Sep. 24, 2026

PridCor Therapeutics Advances Phase 2 SHIELD Study of a Combination Antiviral Regimen for Long COVID Toward Enrollment

Indeterminate GlobeNewswire

Sep. 24, 2026

Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product

Indeterminate GlobeNewswire